GaveKal Capital as of March 31, 2015
Portfolio Holdings for GaveKal Capital
GaveKal Capital holds 29 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Becton, Dickinson and (BDX) | 5.3 | $16M | 108k | 143.59 | |
| Laboratory Corp. of America Holdings | 4.7 | $14M | 110k | 126.09 | |
| Quest Diagnostics Incorporated (DGX) | 4.5 | $13M | 174k | 76.85 | |
| Bristol Myers Squibb (BMY) | 4.1 | $12M | 189k | 64.50 | |
| Eli Lilly & Co. (LLY) | 4.1 | $12M | 165k | 72.65 | |
| Medtronic (MDT) | 4.1 | $12M | 154k | 77.99 | |
| Zimmer Holdings (ZBH) | 4.0 | $12M | 100k | 117.52 | |
| Citrix Systems | 4.0 | $12M | 183k | 63.87 | |
| Henry Schein (HSIC) | 3.9 | $12M | 83k | 139.62 | |
| NVIDIA Corporation (NVDA) | 3.9 | $11M | 544k | 20.93 | |
| Illinois Tool Works (ITW) | 3.8 | $11M | 116k | 97.14 | |
| C.R. Bard | 3.8 | $11M | 66k | 167.35 | |
| Cintas Corporation (CTAS) | 3.6 | $11M | 131k | 81.63 | |
| Xerox Corporation | 3.6 | $11M | 817k | 12.85 | |
| Johnson & Johnson (JNJ) | 3.5 | $11M | 104k | 100.60 | |
| Intuit (INTU) | 3.4 | $10M | 104k | 96.96 | |
| Abbott Laboratories (ABT) | 3.4 | $10M | 215k | 46.33 | |
| Abbvie (ABBV) | 3.4 | $9.9M | 170k | 58.54 | |
| EMC Corporation | 3.2 | $9.5M | 370k | 25.56 | |
| Pepsi (PEP) | 3.2 | $9.4M | 98k | 95.62 | |
| Microsoft Corporation (MSFT) | 3.1 | $9.2M | 227k | 40.66 | |
| Ca | 2.9 | $8.4M | 258k | 32.61 | |
| Varian Medical Systems | 2.9 | $8.4M | 90k | 94.09 | |
| Teradata Corporation (TDC) | 2.6 | $7.7M | 175k | 44.14 | |
| Adobe Systems Incorporated (ADBE) | 2.4 | $7.0M | 95k | 73.94 | |
| 2.3 | $6.8M | 12k | 554.68 | ||
| Applied Materials (AMAT) | 2.2 | $6.6M | 294k | 22.56 | |
| Autodesk (ADSK) | 2.2 | $6.6M | 112k | 58.64 | |
| Corning Incorporated (GLW) | 2.1 | $6.1M | 268k | 22.68 |
